Up­start GeneTx launch­es, go­ing head to head with Ovid on rare An­gel­man syn­drome

An Illi­nois non­prof­it has launched a start­up de­vel­op­ing a drug to treat An­gel­man syn­drome – the ge­net­ic con­di­tion that’s al­so be­ing tack­led by Je­re­my Levin …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER